Geographical variation in Plasmodium vivax relapse

Geographical variation in Plasmodium vivax relapse

Afficher d'autres versions (1)

Background: Plasmodium vivax has the widest geographic distribution of the human malaria parasites and nearly 2.5 billion people live at risk of infection. The control of P. vivax in individuals and populations is complicated by its ability to relapse weeks to months after initial infection. Strains...

Description complète

Détails bibliographiques
Auteurs principaux:	Battle, K, Karhunen, MS, Bhatt, S, Gething, P, Howes, R, Golding, N, Van Boeckel, T, Messina, J, Shanks, G, Smith, D, Baird, J, Hay, S
Format:	Journal article
Langue:	English
Publié:	BioMed Central 2014

Documents similaires

Geographical variation in Plasmodium vivax relapse.
par: Battle, K, et autres
Publié: (2014)

Global epidemiology of Plasmodium vivax
par: Howes, R, et autres
Publié: (2016)

Global Epidemiology of Plasmodium vivax
par: Howes, R, et autres
Publié: (2016)

The global public health significance of Plasmodium vivax.
par: Battle, K, et autres
Publié: (2012)

Growing evidence of Plasmodium vivax across malaria-endemic Africa
par: Twohig, K, et autres
Publié: (2019)

Defining the relationship between Plasmodium vivax parasite rate and clinical disease.
par: Battle, K, et autres
Publié: (2015)

Plasmodium vivax transmission in Africa
par: Howes, R, et autres
Publié: (2015)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
par: Baird, J, et autres
Publié: (2018)

The international limits and population at risk of Plasmodium vivax transmission in 2009
par: Guerra, C, et autres
Publié: (2010)

Primaquine as anti-relapse therapy for Plasmodium vivax
par: Baird, J
Publié: (1998)

Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax.
par: Gething, P, et autres
Publié: (2011)

Plasmodium vivax Transmission in Africa.
par: Rosalind E Howes, et autres
Publié: (2015-11-01)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
par: J. Kevin Baird, et autres
Publié: (2018-01-01)

Growing evidence of Plasmodium vivax across malaria-endemic Africa.
par: Katherine A Twohig, et autres
Publié: (2019-01-01)

Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
par: Baird, J
Publié: (2018)

The epidemiology of Plasmodium vivax. Preface.
par: Hay, S, et autres
Publié: (2013)

A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
par: Gething, P, et autres
Publié: (2012)

The international limits and population at risk of Plasmodium vivax transmission in 2009.
par: Carlos A Guerra, et autres
Publié: (2010-08-01)

CAN THE SPATIAL DISTRIBUTION OF DUFFY NEGATIVITY EXPLAIN PLASMODIUM VIVAX ABSENCE IN AFRICA?
par: Howes, R, et autres
Publié: (2009)

The global burden of Plasmodium vivax malaria is obscure and insidious
par: Battle, KE, et autres
Publié: (2021)

Plasmodium vivax malaria endemicity in Indonesia in 2010
par: Elyazar, I, et autres
Publié: (2012)

Hypnozoite depletion in successive Plasmodium vivax relapses.
par: Rintis Noviyanti, et autres
Publié: (2022-07-01)

Modelling the global constraints of temperature on transmission of <it>Plasmodium falciparum </it>and <it>P. vivax </it>
par: Patil Anand P, et autres
Publié: (2011-05-01)

Attacking Plasmodium vivax
par: Baird, J
Publié: (2016)

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
par: Krudsood, S, et autres
Publié: (2008)

Malaric relapses due to Plasmodium Vivax Reinfección engógena por Plasmodium vivax
par: Cecilia Giraldo, et autres
Publié: (1991-01-01)

Determinants of relapse periodicity in <it>Plasmodium vivax </it>malaria
par: White Nicholas J
Publié: (2011-10-01)

Management of relapsing Plasmodium vivax malaria
par: Chu, C, et autres
Publié: (2016)

The burden of Plasmodium vivax malaria
par: Battle, K
Publié: (2015)

Neglect of Plasmodium vivax malaria.
par: Baird, J
Publié: (2007)

Chloroquine resistance in Plasmodium vivax.
par: Baird, J
Publié: (2004)

Defining the geographical range of the Plasmodium knowlesi reservoir.
par: Moyes, C, et autres
Publié: (2014)

Population heterogeneity in Plasmodium vivax relapse risk.
par: Eva Stadler, et autres
Publié: (2022-12-01)

Estimating geographical variation in the risk of zoonotic Plasmodium knowlesi infection in countries eliminating malaria
par: Shearer, FM, et autres
Publié: (2016)

Pernicious and threatening Plasmodium vivax as reality.
par: Baird, J
Publié: (2014)

Resistance to therapies for infection by Plasmodium vivax.
par: Baird, J
Publié: (2009)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
par: Watson, JA, et autres
Publié: (2021)

Determinants of relapse periodicity in Plasmodium vivax malaria.
par: White, N
Publié: (2011)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
par: James A Watson, et autres
Publié: (2021-05-01)

A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
par: Peter W Gething, et autres
Publié: (2012-01-01)